openPR Logo
Press release

Hepatitis Drugs Market Is Growing Due to Increasing R&D Investments on Hepatitis Research and Drug Discovery

07-11-2019 07:00 AM CET | Advertising, Media Consulting, Marketing Research

Press release from: P&S Intelligence

Hepatitis Drugs Market Is Growing Due to Increasing R&D

The global hepatitis drugs market is growing due to increasing incidences of hepatitis and increasing support from government organizations. In addition, the growing geriatric population, and increasing R&D investments on hepatitis research and drug discovery are also driving the growth of the global hepatitis drugs market.

Access Detailed Report Summary: https://www.psmarketresearch.com/market-analysis/hepatitis-drugs-market

Among the various types, the hepatitis C segment is expected to be the largest segment, and expected to witness the fastest growth during the forecast period, with a CAGR of 30.7%.

The increasing incidences of various types of hepatitis, such as hepatitis B, and hepatitis C are playing a pivotal role in the growth of the global hepatitis drugs market. According to the Hepatitis B Foundation, a non-profit organization solely dedicated to the global problem of hepatitis B, approximately 400 million people globally were chronically infected with hepatitis B, as reported at the end of September 2015. According to the World Health Organization (WHO), an estimated 130 - 150 million people globally were reported to suffer from hepatitis C, as of July 2015. The increasing incidences of hepatitis have increased the demand of therapeutic drugs for the management of diseases.

Request to Get the Sample Pages at: https://www.psmarketresearch.com/market-analysis/hepatitis-drugs-market/report-sample

However, the high capital expenditure and stringent regulatory requirements are inhibiting the growth of the market. The growing number of collaboration and partnerships is one of the latest trends observed in the market.

Make Enquiry Before Buying the Report: https://www.psmarketresearch.com/send-enquiry?enquiry-url=hepatitis-drugs-market

Geographically, North America dominated the global market of hepatitis drugs in 2014; whereas the Asian market is expected to witness the fastest growth, with a CAGR of 32.4% during the forecast period.

About P&S Intelligence
P&S Intelligence is a provider of market research and consulting services catering to the market information needs of burgeoning industries across the world. Providing the plinth of market intelligence, P&S as an enterprising research and consulting company, believes in providing thorough landscape analyses on the ever-changing market scenario, to empower companies to make informed decisions and base their business strategies with astuteness.

Contact:
P&S Intelligence
Toll-free: +1-888-778-7886 (USA/Canada)
International: +1-347-960-6455
Email: enquiry@psmarketresearch.com
Web: https://www.psmarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Hepatitis Drugs Market Is Growing Due to Increasing R&D Investments on Hepatitis Research and Drug Discovery here

News-ID: 1801407 • Views: 193

More Releases from P&S Intelligence

E-Signature Market Is Expected To Reach $12,721.5 Million by 2030
An electronic signature, often known as an e-signature, is a way to digitally sign contracts and other documents without using pen or paper. When carried out following e-signature legislation, electronic signatures have the same legal enforceability and validity as pen-and-paper documents, helping businesses save time and money. Why Is E-Signature Software Necessary for Businesses? In many firms, an average day is devoted to paperwork-contracts and other forms that must be completed, signed,
Slicing Software Market is predicted to Witness 16.7% CAGR during 2020-2030
The global slicing software market is predicted to reach a value of $2,202.5 million by 2030, rising from $422.2 million in 2019, progressing at a 16.7% CAGR during the forecast period (2020-2030), as per a report by P&S Intelligence. The primary factors leading to the growth of the market are the requirement for enhanced manufacturing speed, need for integrated slicing software, and increasing utilization of 3D printing in aerospace, healthcare,
Huge Revenue Explosion Expected in Global Certificate Authority Market From 2019 …
The global certificate authority market generated a revenue of $81.7 million in 2019 and is predicted to attain a value of $285.7 million in 2030, exhibiting a CAGR of 12.3% between 2020 and 2030. The key factors fueling the advancement of the market are the rising public awareness about protected and secure web access, increasing penetration of the internet, surging number of transactions that require authentication and a secure connection,
Global Webgame Market Set to Generate Over $6.0 Billion Revenue by 2030
The global webgame market generated a revenue of $3.5 billion in 2019 and is predicted to attain a valuation of $6.5 billion by 2030. According to the estimates of P&S Intelligence, a market research firm based in India, the market would progress at a CAGR of 5.7% between 2020 and 2030. The growing usage of tablets and smartphones and the increasing utilization of social media are the prominent two factors

All 5 Releases


More Releases for Hepatitis

Is Hepatitis A Vaccine Required?
Hepatitis A Vaccine Market describes its growth, size, share, Forecast and trends to 2025 Hepatitis A vaccine is a vaccine which is against the hepatitis A virus. The Hepatitis A vaccine is available for long-term prevention of HAV infection, Minimum age for HAV vaccination is 1 year. Two types of HAV vaccines are currently available internationally: 1. Formaldehyde-inactivated vaccines: Inactivated HAV vaccines are used in most countries. Monovalent inactivated HAV vaccines are available
Hepatitis B Therapeutics Market Is Driven by Rising Incidence of Hepatitis B In …
Hepatitis B is a life threatening liver infection caused by hepatitis B virus. Adults who get affected by hepatitis B virus for a short time and then get cured is known as acute hepatitis B. Infection that lasts for a long time is known as chronic hepatitis B. Vaccine is the most preferred choice of doctors and physicians to protect people from the disease. The vaccine prevents the infection and
Hepatitis E Hyperendemicity to Drive Hepatitis E Diagnostic Tests Market Growth
Global Hepatitis E Diagnostic Tests Market: Snapshot The growing incidence of hepatitis E, a liver disease caused by infection due to the virus hepatitis E virus (HEV), is a leading cause of morbidity and mortality worldwide. There is increasing prevalence of hepatitis E in resource-limited region, such as various countries of Asia Pacific. The people of these regions suffer with frequent water contamination and have limited access to sanitation and hygiene,
Hepatitis Drug Market Hepatitis Drug Clinical Pipeline Report 2023
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990 Report Table of Contents 1. Introduction to Hepatitis Disease 1.1 Prologue 1.1.1 History of Hepatitis 1.1.2 Causes of Hepatitis Disease 1.2 Types of Viruses which are Responsible for Hepatitis Disease 2. Global Prevalence of Hepatitis Infection 3. Available Drug Classes for Hepatitis Disease Treatment 3.1 Interferon Alfa Therapy 3.2 Protease Inhibitors Therapy 3.3 Polymerase
Hepatitis C Drug Pipeline Analysis
“Hepatitis C Drug Pipeline Analysis” by PNS Pharma gives comprehensive insight on the various drug profiles being developed for the treatment of Hepatitis C. Research report covers all the ongoing drug development in various phases. Each drug profiles include detailed information like: Originator, Owner, Collaborator, Technology Provider, Licensee, Development Phase, Development Indications, Mechanism of Action, Chemical Formula, Country of Development and detailed analysis on the development process. Insight for each
Hepatitis C Drug Market: Global Hepatitis C Drug Share Will Reach $27.63 billion …
Zion Market Research has published a new report titled “Hepatitis C Drug Market for (Hospitals, Private Labs, Physician Offices, Public Health Labs and Blood Banks) by Application – Global Industry Perspective, Comprehensive Analysis and Forecast, 2015 – 2021” According to the report, global demand for hepatitis C drug market was valued at USD 11.81 billion in 2015, is expected to reach USD 27.63 billion in 2021 and is anticipated to